Kestra Advisory Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
VCM
VPM
EIG
Kestra Advisory Services's DGX Position: Q1 2026 in Review
Kestra Advisory Services held its Quest Diagnostics (DGX) position steady in Q1 2026 at 17,886 shares worth $3.51M. The position accounts for 0.01% of the portfolio, ranked #982.
Kestra Advisory Services first reported a position in DGX in Q3 2020 and has held it in 23 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Kestra Advisory Services held 17,886 shares of Quest Diagnostics worth $3.51M as of Q1 2026.
- Kestra Advisory Services left its Quest Diagnostics share count unchanged in Q1 2026.
- Quest Diagnostics made up 0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #982 holding.
- Kestra Advisory Services first reported a position in Quest Diagnostics in Q3 2020 and has held it in 23 quarters since.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.